Oncologists Accepting Blue Cross Blue ShieldPage 14

David Kwiatkowski, MD

Professor of Medicine at Harvard Medical School, and Senior Physician at Brigham and Women’s Hospital/Dana-Farber Cancer Institute. He earned a BSc from Caltec; Senior Physician

Oncology

James Rubenstein, MD

Hematology Oncology

Oncology

Michael Atkins, M.D.

Oncology

Saumil Gandhi, MD

Associate Professor, Department of Radiation Oncology, Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX

Oncology

Peter Liu, MD

Oncology

Edward Wolin, M.D.

Professor of Medicine, Hematology and Medical Oncology; Director, Center for Carcinoid and Neuroendocrine Tumors

Oncology

Brian Badgwell, M.D.

Professor of Surgery, Hamill Foundation Distinguished Professorship in Honor of Dr. Richard G. Martin, Sr, Division of Surgery, The University of Texas MD Anderson Cancer Center

Oncology

Gary Ulaner, M.D. PH.D.

James & Pamela Muzzy Endowed Chair of Molecular Imaging and Therapy (MIT); Director, Molecular Imaging and Therapy; Professor of Radiology and Translational Genomics, University of Southern California

Oncology

Gul Moonis, MD

Professor, Department of Radiology, NYU Grossman School of Medicine

Oncology

Eric Lis, MD

Oncology

Lecia Sequist, MD

Associate Professor of Medicine, Harvard Medical School; Mary B. Saltonstall Endowed Chair in Oncology, Massachusetts General Hospital Cancer Center

Oncology

Alicia Morgans, MD

Director of the Survivorship Program at Dana-Farber Cancer Institute. A clinician and investigator, she has expertise in clinical trials and patient-reported; Director, Survivorship Program

Oncology

Arkadiusz Dudek, M.D.

Professor of Medicine, Division of Hematology, Oncology, and Transplantation

Oncology

Frank Hodi, MD

Professor of Medicine, Harvard Medical School; Director, Melanoma Center and Center for Immuno-Oncology, Dana-Farber Brigham Cancer Center

Oncology

Susan Domchek, MD

Basser Professor in Oncology; Executive Director, Basser Center for BRCA; Director, Cancer Risk Evaluation Program

Oncology

Kate Lathrop, M.D.

Associate Professor/Clinical; Program Director, Medical Oncology and Hematology Fellowship Program; Assistant Dean of Undergraduate Research, Long School of Medicine

Oncology

Elizabeth Shpall, M.D.

Professor and Chair ad interim, Department of Stem Cell Transplantation and Cellular Therapy; Director, Cell Therapy Laboratory; Director, Cord Blood Bank; Howard and Lee Smith Chair in Cancer Research

Oncology

Amita Patnaik, M.D.

Co-Director of Clinical Research, START Center for Cancer Research; Co-Founder of START; Director, START Fellowship Program

Oncology

Henry Pitot, M.D.

Associate Professor, Oncology

Oncology

Efrat Dotan, MD

Executive Medical Director

Oncology